121 related articles for article (PubMed ID: 12467962)
1. Genetic background as a possible determinant of clinical and biological features of Epstein-Barr virus infection--a hypothetical view.
Mizutani S
Crit Rev Oncol Hematol; 2002 Dec; 44(3):217-25. PubMed ID: 12467962
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus-associated smooth muscle tumors in ataxia-telangiectasia: a case report and review.
Reyes C; Abuzaitoun O; De Jong A; Hanson C; Langston C
Hum Pathol; 2002 Jan; 33(1):133-6. PubMed ID: 11823985
[TBL] [Abstract][Full Text] [Related]
3. Gene expression analysis in EBV-infected ataxia-telangiectasia cell lines by RNA-sequencing reveals protein synthesis defect and immune abnormalities.
Tatfi M; Perthame E; Hillion KH; Dillies MA; Menager H; Hermine O; Suarez F
Orphanet J Rare Dis; 2021 Jun; 16(1):288. PubMed ID: 34183044
[TBL] [Abstract][Full Text] [Related]
4. miR-18a reactivates the Epstein-Barr virus through defective DNA damage response and promotes genomic instability in EBV-associated lymphomas.
Cao P; Zhang M; Wang L; Sai B; Tang J; Luo Z; Shuai C; Zhang L; Li Z; Wang Y; Li G; Xiang J
BMC Cancer; 2018 Dec; 18(1):1293. PubMed ID: 30594162
[TBL] [Abstract][Full Text] [Related]
5. Epstein-barr virus-associated extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT Lymphoma) arising in the parotid gland of a child with ataxia telangiectasia.
Bennett JA; Bayerl MG
J Pediatr Hematol Oncol; 2015 Mar; 37(2):e114-7. PubMed ID: 25692616
[TBL] [Abstract][Full Text] [Related]
6. Clonal expansion of multiphenotypic Epstein-Barr virus-infected lymphocytes in chronic active Epstein-Barr virus infection.
Endo R; Yoshioka M; Ebihara T; Ishiguro N; Kikuta H; Kobayashi K
Med Hypotheses; 2004; 63(4):582-7. PubMed ID: 15325000
[TBL] [Abstract][Full Text] [Related]
7. Mouse model for acute Epstein-Barr virus infection.
Wirtz T; Weber T; Kracker S; Sommermann T; Rajewsky K; Yasuda T
Proc Natl Acad Sci U S A; 2016 Nov; 113(48):13821-13826. PubMed ID: 27856754
[TBL] [Abstract][Full Text] [Related]
8. Host genetics of Epstein-Barr virus infection, latency and disease.
Houldcroft CJ; Kellam P
Rev Med Virol; 2015 Mar; 25(2):71-84. PubMed ID: 25430668
[TBL] [Abstract][Full Text] [Related]
9. Telomerase activity impacts on Epstein-Barr virus infection of AGS cells.
Rac J; Haas F; Schumacher A; Middeldorp JM; Delecluse HJ; Speck RF; Bernasconi M; Nadal D
PLoS One; 2015; 10(4):e0123645. PubMed ID: 25856387
[TBL] [Abstract][Full Text] [Related]
10. Cell reservoirs of the Epstein-Barr virus in biopsy-proven lymphocytic interstitial pneumonitis in HIV-1 subtype E infected children: identification by combined in situ hybridization and immunohistochemistry.
Bhoopat L; Rangkakulnuwat S; Okonogi R; Wannasai K; Bhoopat T
Appl Immunohistochem Mol Morphol; 2010 May; 18(3):212-8. PubMed ID: 19801937
[TBL] [Abstract][Full Text] [Related]
11. Efficient Translation of Epstein-Barr Virus (EBV) DNA Polymerase Contributes to the Enhanced Lytic Replication Phenotype of M81 EBV.
Church TM; Verma D; Thompson J; Swaminathan S
J Virol; 2018 Mar; 92(6):. PubMed ID: 29263273
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr Virus Type 2 Infects T Cells and Induces B Cell Lymphomagenesis in Humanized Mice.
Coleman CB; Lang J; Sweet LA; Smith NA; Freed BM; Pan Z; Haverkos B; Pelanda R; Rochford R
J Virol; 2018 Nov; 92(21):. PubMed ID: 30089703
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus and gastric carcinoma.
Fukayama M
Pathol Int; 2010 May; 60(5):337-50. PubMed ID: 20518883
[TBL] [Abstract][Full Text] [Related]
14. A review of the cytomorphology of Epstein-Barr virus-associated malignancies.
Michelow P; Wright C; Pantanowitz L
Acta Cytol; 2012; 56(1):1-14. PubMed ID: 22236740
[TBL] [Abstract][Full Text] [Related]
15. The biological properties of different Epstein-Barr virus strains explain their association with various types of cancers.
Tsai MH; Lin X; Shumilov A; Bernhardt K; Feederle R; Poirey R; Kopp-Schneider A; Pereira B; Almeida R; Delecluse HJ
Oncotarget; 2017 Feb; 8(6):10238-10254. PubMed ID: 28052012
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr Virus (EBV) Latent Protein EBNA3A Directly Targets and Silences the
Bazot Q; Paschos K; Allday MJ
J Virol; 2018 Apr; 92(7):. PubMed ID: 29367247
[TBL] [Abstract][Full Text] [Related]
17. Interferon-γ-inducible protein 16 (IFI16) is required for the maintenance of Epstein-Barr virus latency.
Pisano G; Roy A; Ahmed Ansari M; Kumar B; Chikoti L; Chandran B
Virol J; 2017 Nov; 14(1):221. PubMed ID: 29132393
[TBL] [Abstract][Full Text] [Related]
18. Clonal origin of Epstein-Barr virus (EBV)-infected T/NK-cell subpopulations in EBV-positive T/NK-cell lymphoproliferative disorders of childhood.
Ohga S; Ishimura M; Yoshimoto G; Miyamoto T; Takada H; Tanaka T; Ohshima K; Ogawa Y; Imadome K; Abe Y; Akashi K; Hara T
J Clin Virol; 2011 May; 51(1):31-7. PubMed ID: 21377409
[TBL] [Abstract][Full Text] [Related]
19. High frequencies of asymptomatic Epstein-Barr virus viremia in affected and unaffected individuals with CTLA4 mutations.
Hoshino A; Tanita K; Kanda K; Imadome KI; Shikama Y; Yasumi T; Imai K; Takagi M; Morio T; Kanegane H
Clin Immunol; 2018 Oct; 195():45-48. PubMed ID: 30048690
[TBL] [Abstract][Full Text] [Related]
20. Characterization of Epstein-Barr virus infection in a human signet ring cell gastric carcinoma cell line, HSC-39.
Luo B; Murakami M; Fukuda M; Fujioka A; Yanagihara K; Sairenji T
Microbes Infect; 2004 Apr; 6(5):429-39. PubMed ID: 15109957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
